Biosensor

A biosensor is a device for the detection of an analyte that combines a biological component with a physicochemical detector component.

What are Biosensors?

The term “biosensor” is short for “biological sensor.” The device is made up of a transducer and a biological element that may be an enzyme, an antibody or a nucleic acid. The bioelement interacts with the analyte being tested and the biological response is converted into an electrical signal by the transducer. Depending on their particular application, biosensors are also known as immunosensors, optrodes, resonant mirrors, chemical canaries, biochips, glucometers and biocomputers.

What are Nanoelectronic Biosensors?

Nanoelectronic Biosensor Applications in Human Diseases

Nanoelectronic Biosensor Development

Biosensor Applications

Biosensors and Food Industry

Biosensor Principles

Surface Attachment of Biological Elements

Latest Biosensor News and Research

New insights into brain fueling could lead to treatments for stroke, neurodegeneration

A new Yale study has revealed that neurons - the energy-hungry cells that connect and direct activity in the brain - are equipped with "backup batteries" that kick in to keep the brain running during periods of metabolic stress.

18 Jul 2025

New biosensor uses light and AI to detect cancer in its earliest stages

Dr. Ho Sang Jung and his research team from the Advanced Bio and Healthcare Materials Research Division at the Korea Institute of Materials Science(KIMS) have developed an optical biosensor capable of detecting trace amounts of cancer cell DNA in the bloodstream with high sensitivity, enabling early cancer diagnosis.

10 Jul 2025

Coffee ring effect inspires breakthrough in rapid at-home tests for disease detection

Got a sore throat and the sniffles? The recent rise of rapid at-home tests has made it easier to find out if you have a serious illness like COVID-19 or just a touch of spring allergies.

8 Jul 2025

Evosep joins P4ML to power world’s largest multi-omic human health study of two million samples

Evosep, a global leader in robust, high-throughput proteomics technologies, has been selected as the proteomics platform provider for the P4ML - OMICAssist Study—the world's largest multi-omic precision medicine initiative, launched by P4ML alongside its strategic academic, health regulatory, and semi-state partners in the United Arab Emirates.

From Evosep 17 Jun 2025

New electrochemical device advances point-of-care HIV diagnostics

Accurate monitoring of CD4+ T cell counts is vital for evaluating immune health and guiding treatment in people living with Human Immunodeficiency Virus (HIV).

30 May 2025

Advancing GPCR drug discovery with fragment screening using GCI technology

Evotec's insights into GPCRs and waveRAPID technology reveal new opportunities in drug discovery, focusing on orphan receptors and innovative screening methods.

From Creoptix (A Malvern Panalytical brand) 23 May 2025

WHO and Medicines Patent Pool support Nigerian innovation in health diagnostics

The World Health Organization (WHO) and Medicines Patent Pool (MPP) have today announced a sublicensing agreement between MPP and a Nigerian health technology company – Codix Bio – to start development and manufacturing of rapid diagnostic tests (RDTs) using technology transferred from global in-vitro diagnostics company – SD Biosensor (SDB).

9 May 2025

New biosensor offers fast detection of H5N1 in farm air

As highly pathogenic H5N1 avian influenza continues to spread in the U.S., posing serious threats to dairy and poultry farms, both farmers and public health experts need better ways to monitor for infections, in real time, to mitigate and respond to outbreaks.

24 Apr 2025

Northwestern scientists develop rapid HIV test for point-of-care diagnosis

A team of Northwestern University scientists spanning disciplines have developed new technology that could lead to the creation of a rapid point-of-care test for HIV infection competitive with traditional lab-based HIV testing in a fraction of the time and without the need for a stressful wait while results are processed or confirmed in a clinical laboratory.

2 Apr 2025

New tool visualizes immune response to abnormal DNA

A research led by Sergio P. Acebrón, Researcher Ikerbasque at the UPV/EHU, develops a key tool to visualize the immune response to abnormal DNA, opening new avenues for the treatment of diseases.

19 Mar 2025

New sensor offers rapid detection of airborne bird flu virus

Recent outbreaks of highly pathogenic avian influenza (also known as bird flu) have created a need for rapid and sensitive detection methods to mitigate its spread.

7 Mar 2025

University of Oulu advances biosensor technology for disease detection

The University of Oulu is at the forefront of developing cutting-edge biosensor technology that could revolutionize the early diagnosis and treatment of diseases.

10 Feb 2025

Enhanced biosensing technology detects molecules at lower concentrations

An unplugged electric instrument may function, but it sounds much better when it is connected to an amplifier.

13 Jan 2025

Groundbreaking G6PD diagnostic test prequalified by WHO to ensure safe malaria treatment

On 18 December 2024, the World Health Organization (WHO) prequalified the first diagnostic test for glucose-6-phosphate dehydrogenase (G6PD) deficiency which can help to safely deliver WHO-recommended treatments to prevent relapse of Plasmodium vivax (P. vivax) infection.

9 Jan 2025